How Long Does Vision Therapy Take? An Honest Timeline

One of the first questions we hear at Vision & Learning Center is, “How long is this going to take?” It is a fair question. You are being asked to commit time, money and a weekly slot in an already full schedule.

Here is our honest answer. Most of our programs run about 18 to 24 weeks. Some patients finish in as little as 12 weeks. Complex cases can run a year or longer. That range is not vagueness for its own sake. It reflects what the research shows about how long different visual problems take to change.

Key takeaways

• Our typical program is 18 to 24 weeks, with a realistic floor around 12 weeks and complex cases running 1 to 2 years.
• The trials give real benchmarks. The Convergence Insufficiency Treatment Trial ran 12 weeks and CITT-ART ran 16 weeks, both weekly office visits plus home practice.
• Amblyopia is measured in months, not weeks. Glasses alone can keep improving a lazy eye for up to 30 weeks, and patching trials report their main outcome at 4 months.
• Adherence is part of the dose. In electronically monitored patching, acuity gains tracked the hours actually done (Stewart et al., 2004), and when a trial logged treatment time instead of trusting reports, only 22.2% of children did more than 75% of what was prescribed (Holmes et al., 2016).
• We measure signs, not just feelings. Be skeptical of anyone promising a fixed number of weeks before they know the diagnosis.

Why the range is so wide

Vision therapy is not one treatment. It is a category of treatments aimed at very different problems, and the timeline follows the diagnosis.

A teenager with symptomatic convergence insufficiency and no other findings is a different project from a seven-year-old with amblyopia, suppression and a history of eye muscle surgery. The first is largely about building fusional range and stamina. The second means asking the brain to start using an eye it has spent years learning to ignore. Both are worth doing. They do not take the same amount of time.

What the research says about the clock

Convergence insufficiency: 12 to 16 weeks in the trials

The best evidence in our field comes from the Convergence Insufficiency Treatment Trial. In 221 children aged 9 to 17, the winning arm was 12 weeks of weekly 60-minute office visits plus 15 minutes of home therapy five days a week. After those 12 weeks, 73% of that group were classed as successful or improved, compared with 43% for home pencil push-ups, 33% for home computer therapy and 35% for office-based placebo therapy (CITT Study Group, 2008). A Cochrane network meta-analysis of 12 trials and 1,289 participants reached the same conclusion for children (Scheiman et al., 2020).

The follow-up trial, CITT-ART, ran 16 weeks. Clinical signs improved more with real therapy than with placebo: near point of convergence improved 10.4 cm versus 6.2 cm, and fusional vergence 23.2 versus 8.8 prism diopters (CITT-ART, 2019).

Two results in that same trial deserve equal billing, because they set expectations about what those weeks can buy. Symptom scores improved in the placebo group about as much as in the therapy group. And reading comprehension improved 3.7 points with therapy versus 3.8 points with placebo, meaning therapy was no better than placebo for reading (CITT-ART, 2019). We go through the wider evidence, condition by condition, in does vision therapy work: an honest evidence summary.

So 12 to 16 weeks is a defensible benchmark for straightforward, symptomatic convergence insufficiency in a child. It is not a promise, and it says nothing about reading scores.

Do the gains hold after the program ends?

Reasonably well, in the patients who responded. Of the children who became asymptomatic after the 12-week CITT program and were followed for a year, 84.4% of the office-based therapy group were still asymptomatic (CITT Study Group, 2009), and among the children who had reduced accommodative amplitude to begin with, it had come back a year later in only 12.5% (Scheiman et al., 2011). Only children who had already responded were followed, so this describes durability in responders, not everyone.

Adults: fewer weeks are not the issue

The adult evidence is thinner. In a trial of 46 adults aged 19 to 30, symptom-elimination criteria were met by 42% with office-based therapy versus 31% with placebo, and more than half of treated adults remained symptomatic (Scheiman et al., 2005). We treat adults and many do well, but we will not quote them a children’s timeline as though the evidence were the same.

Amblyopia and strabismus: measured in months

Amblyopia works on a different clock, and the research is clear about it.

• Glasses alone keep working for months. In 84 children with untreated anisometropic amblyopia, spectacles alone improved acuity by 2 or more lines in 77% and resolved the amblyopia in 27%, with improvement continuing for up to 30 weeks before it stabilized (Cotter et al., 2006). That is why a good plan often starts with a period of glasses only.
• Patching is front-loaded but measured in months. With electronically monitored patching, more than 80% of the improvement during occlusion happened in the first 6 weeks, and the dose-response was linear (Stewart et al., 2004). Even so, the large PEDIG patching trial reported its primary outcome at 4 months, where 2 hours and 6 hours a day produced the same 2.40-line gain (Repka et al., 2003).
• Older children still respond, more slowly. Among 7 to 12-year-olds, 53% responded to 2 to 6 hours of daily patching with near activities plus atropine, versus 25% with glasses alone, though most were left with some residual deficit (Scheiman et al., 2005).
• “Finished” rarely means perfect. At age 15, 59.9% of children treated before age 7 saw 20/25 or better in the amblyopic eye, but 48.3% still had a 2-line or greater difference between the eyes (Repka et al., 2014).

When we say amblyopia and strabismus cases usually take longer, that is what we are drawing on. Prior strabismus surgery adds to it, because surgery addresses alignment while therapy addresses how the two eyes work together. Those are different jobs.

Why adherence changes your timeline more than anything else

This is the part most people underestimate, and it is the part they control.

The CITT program was not weekly office visits alone. It was weekly office visits plus 15 minutes of home therapy, five days a week, and the home-only arms of that trial performed far worse than the supervised arm with home reinforcement (CITT Study Group, 2008). Home practice is not homework tacked onto the real treatment. It is part of the dose.

When researchers look at what people actually did rather than what was prescribed, the picture gets sobering. In a PEDIG trial of a binocular iPad game for amblyopia, only 22.2% of children completed more than 75% of the prescribed play, and the game underperformed patching (Holmes et al., 2016). In a real-world review of 218 post-concussion records, vision therapy was recommended for 80% of the patients, and only 54% of those (95 of 175) completed it, though 85% of the convergence insufficiency patients who did complete it were classed as successful (Gallaway et al., 2017).

Our clinical perspective. Missed weeks do not simply push the end date back by the weeks missed. Progress is cumulative, and long gaps mean re-establishing skills that had started to become automatic. The families who finish nearest the short end of our range are almost always the ones who protect the appointment and do the 10 to 15 minutes at home. More on that in the importance of consistency in vision therapy.

What else moves the number

Diagnosis and severity. A single, recently developed eye-teaming or focusing problem tends to move faster than one layered with suppression, amblyopia, strabismus or years of adaptation.

Prior treatment history. Patients who have had eye muscle surgery often still need therapy afterward, and those programs are usually longer. That is not a criticism of the surgery, just a more complex visual history.

Age and readiness. Age matters, but not simply. Some young children move quickly because the visual system is adaptable; others need a slower pace for attention and stamina. Plenty of teens and adults do well precisely because they understand why they are doing it. The better predictor is age plus readiness and follow-through, which is what we weigh in who is a good fit for vision therapy.

Goals. Reducing headaches during homework is a shorter project than rebuilding stable binocular function for a full workday at a screen.

When patients usually notice a change

In our experience, comfort and stamina tend to shift before anything else: fewer headaches at homework, less eye strain by the end of a school day, more endurance before near work becomes a fight. Functional changes at school or work usually build more gradually.

We hold that observation loosely, and here is why. In CITT-ART, symptom scores improved in the placebo group about as much as in the therapy group (CITT-ART, 2019). Feeling better is real and it matters, but it is not by itself proof that the visual system changed. That is why we re-measure near point of convergence, fusional ranges, accommodative amplitude and facility at each progress check, and why we would rather show you a measurement than ask you to take our word for it.

What if progress is slower than expected?

Slower than expected does not automatically mean it is not working. It usually means one of four things: the case is more complex than the first evaluation suggested, adherence has slipped, the plan needs adjusting, or the system genuinely needs more time. What it should always mean is a conversation. If the measurements are not moving after a reasonable stretch, the right response is to re-examine, change the plan, or tell you honestly that this is not the treatment that will help.

How we decide therapy is complete

Not by the calendar. A program is complete when the goals have been met at a level that holds: symptoms meaningfully reduced, clinical measures improved and stable across visits, and the gains showing up outside the therapy room.

Before you commit to a program anywhere, ask five questions: What is the diagnosis? What does the evidence show for that diagnosis specifically? How many weeks do you expect? How will progress be measured? What happens if the measurements do not move? Our FAQ page covers more of these, and if the number of weeks is on your mind mostly because of what it costs, see what changes the price of vision therapy and our overview of how our vision therapy programs are structured.

Where to start

We cannot tell you how long your program will take until we know what we are treating. A comprehensive developmental vision evaluation gives us the diagnosis, the severity and the starting measurements, and those three things are what produce a realistic timeline instead of a guess.

If near work is uncomfortable, if reading brings on headaches or double vision, or if a lazy eye or eye turn has never been fully addressed, schedule an evaluation or read what our examinations include.